{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-051144","form_type":"8-K","ticker":"ABVC","cik":"0001173313","company_name":"ABVC BIOPHARMA, INC.","filed_at":"2025-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.697245+00:00","generated_at":"2026-05-19T23:39:13.662332+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"ABVC BioPharma shareholders approve all four proposals including related-party land deal","bullets":["11 directors re-elected with ~5.9M votes for each; 18,525 withheld per director.","Simon & Edward, LLP ratified as auditor for FY2025 with 5,903,606 votes for.","Land purchase from director Shuling Jiang approved (5,832,130 for); may exceed 20% of outstanding shares.","Equity incentive plan increased to 15% of outstanding shares with annual auto-increase approved (5,691,168 for).","Quorum of 5,917,309 shares (35.27% voting power) present for annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-051144","json":"https://secwatch.observer/filing/0001213900-25-051144.json","markdown":"https://secwatch.observer/filing/0001213900-25-051144.md","text":"https://secwatch.observer/filing/0001213900-25-051144.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173313/000121390025051144/0001213900-25-051144-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173313/000121390025051144/ea024460401-8k_abvcbio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T23:39:13.662332+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}